Company Description
Cencora, Inc. sources and distributes pharmaceutical products.
The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.
Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry.
The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023.
Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
| Country | United States |
| Founded | 2001 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 46,000 |
| CEO | Steven H. Collis |
Contact Details
Address: 1 West First Avenue Conshohocken, Pennsylvania 19428 United States | |
| Phone | (610) 727-7000 |
| Website | amerisourcebergen.com |
Stock Details
| Ticker Symbol | COR |
| Exchange | NYSE |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001140859 |
| CUSIP Number | 03090BBJ8 |
| ISIN Number | US03073E1055 |
| Employer ID | 23-3079390 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Steven H. Collis | Chairman, President and Chief Executive Officer |
| James F. Cleary Jr. | Executive Vice President and Chief Financial Officer |
| Dr. Robert P. Mauch Ph.D., PharmD | Executive Vice President and Chief Operating Officer |
| Gina K. Clark | Executive Vice President and Chief Communications and Administration Officer |
| Elizabeth S. Campbell | Executive Vice President and Chief Legal Officer |
| Lazarus Krikorian | Senior Vice President, Chief Accounting Officer and Corporate Controller |
| Bennett S. Murphy | Senior Vice President of Investor Relations |
| Jennifer E. Dubas | Senior Vice President and Chief Compliance Officer |
| Silvana Battaglia | Executive Vice President and Chief Human Resources Officer |
| Leslie E. Donato | Executive Vice President and Chief Strategy Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 15, 2024 | 144 | Filing |
| Mar 19, 2024 | 144 | Filing |
| Mar 18, 2024 | 144 | Filing |
| Mar 18, 2024 | 144 | Filing |
| Mar 15, 2024 | 8-K/A | [Amend] Current report |
| Mar 15, 2024 | 8-K | Current Report |
| Mar 12, 2024 | 8-K | Current Report |
| Feb 27, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |